| Net Cash Provided by (Used in) Operating Activities |
$14,033,797 |
USD |
-82% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$245,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,700 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
150,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
13,443,740 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$5,605,214 |
USD |
-90% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,899,658 |
USD |
-58% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$9,023 |
USD |
|
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
$32,604,279 |
USD |
20% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$18,488,964 |
USD |
-43% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$19,980,310 |
USD |
16% |
Q4 2024 |
FY 2024 |
| Amortization of Intangible Assets |
$30,192 |
USD |
-30% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$30,192 |
USD |
-30% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$32,600,000 |
USD |
20% |
Q4 2024 |
FY 2024 |